Back
IMVT long @ 24.88

Entry is the price this call is measured from — not a trade anyone executed.

10.10 19.59 29.07 38.55 48.04 Dec 27 Jun 13 Nov 28 May 15 Oct 30 apesalpha.com TRADED Jan 13 ENTRY 24.88
Entry 24.88 At close 29.17 +17.2% vs entry 451 sessions since the post 2024-12-27 → 2026-10-30 weekly bars traded Jan 13, filed later

Roivant Sciences Ltd. has been buying IMVT.

  1. The buy: Roivant Sciences Ltd., a Director, bought 16,845,010 shares of IMVT on 13 January 2025 — $336,900,200 at $20.00 a share.
  2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
  3. Filed: 15 January 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.

· Wed, 15 Jan 2025 · · 5 views 5 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.